|
🐜
|
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
15 auth.
Gerry Coghlan,
C. Denton,
E. Grünig,
D. Bonderman,
O. Distler,
D. Khanna,
U. Müller-Ladner,
Janet E. Pope,
M. Vonk,
M. Doelberg,
...
H. Chadha‐Boreham,
H. Heinzl,
Daniel M Rosenberg,
Vallerie V Mclaughlin,
James R. Seibold
|
9 |
2013 |
9
🐜
|
|
🐬
|
Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding
I. Lang,
R. Pesavento,
D. Bonderman,
J. Yuan
|
8 |
2012 |
8
🐬
|
|
🐜
|
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
50 auth.
J. Teerlink,
R. Diaz,
G. Felker,
J. McMurray,
M. Metra,
S. Solomon,
K. Adams,
I. Anand,
Alexandra Arias-Mendoza,
T. Biering-Sørensen,
M. Böhm,
D. Bonderman,
J. Cleland,
R. Corbalán,
M. Crespo-Leiro,
...
U. Dahlström,
L. E. Echeverría,
J. Fang,
G. Filippatos,
C. Fonseca,
E. Goncalvesova,
A. Goudev,
J. Howlett,
D. Lanfear,
Jing Li,
M. Lund,
P. Macdonald,
V. Mareev,
S. Momomura,
E. O’Meara,
A. Parkhomenko,
P. Ponikowski,
F. Ramires,
P. Serpytis,
K. Sliwa,
J. Špinar,
T. Suter,
J. Tomcsányi,
H. Vandekerckhove,
D. Vinereanu,
A. Voors,
M. Yılmaz,
F. Zannad,
L. Sharpsten,
J. Legg,
C. Varin,
Narimon Honarpour,
Siddique A Abbasi,
F. Malik,
C. Kurtz
|
8 |
2020 |
8
🐜
|
|
🦁
|
Mechanisms underlying aortic dilatation in congenital aortic valve malformation.
D. Bonderman,
E. Gharehbaghi-Schnell,
G. Wollenek,
G. Maurer,
H. Baumgartner,
I. Lang
|
8 |
1999 |
8
🦁
|
|
🦁
|
Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction: A Phase IIb Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Hemodynamic Study
11 auth.
D. Bonderman,
S. Ghio,
S. Felix,
H. Ghofrani,
E. Michelakis,
V. Mitrović,
...
R. Oudiz,
Francis Boateng,
A. Scalise,
L. Roessig,
M. Semigran
|
8 |
2013 |
8
🦁
|
|
🐜
|
Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension
12 auth.
G. Simonneau,
A. Torbicki,
M. Hoeper,
M. Delcroix,
K. Karlócai,
N. Galiè,
...
B. Degano,
D. Bonderman,
M. Kurzyna,
M. Efficace,
R. Giorgino,
I. Lang
|
8 |
2012 |
8
🐜
|
|
🦁
|
Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension
11 auth.
D. Bonderman,
J. Jakowitsch,
C. Adlbrecht,
M. Schemper,
P. Kyrle,
V. Schönauer,
...
M. Exner,
W. Klepetko,
M. Kneussl,
G. Maurer,
I. Lang
|
8 |
2005 |
8
🦁
|
|
🦁
|
Predictors of Outcome in Chronic Thromboembolic Pulmonary Hypertension
9 auth.
D. Bonderman,
N. Skoro-Sajer,
J. Jakowitsch,
C. Adlbrecht,
D. Dunkler,
S. Taghavi,
...
W. Klepetko,
M. Kneussl,
I. Lang
|
8 |
2007 |
8
🦁
|
|
🦁
|
Artificial intelligence in cardiology
D. Bonderman
|
8 |
2017 |
8
🦁
|
|
🦁
|
High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension
12 auth.
D. Bonderman,
P. Turecek,
J. Jakowitsch,
A. Weltermann,
C. Adlbrecht,
B. Schneider,
...
M. Kneussl,
L. Rubin,
P. Kyrle,
W. Klepetko,
G. Maurer,
I. Lang
|
7 |
2003 |
7
🦁
|
|
🦁
|
Risk factors for chronic thromboembolic pulmonary hypertension
13 auth.
D. Bonderman,
H. Wilkens,
S. Wakounig,
H. Schäfers,
P. Jansa,
J. Lindner,
I. Simkova,
A. Martischnig,
J. Dudczak,
R. Sadushi,
...
N. Skoro-Sajer,
W. Klepetko,
I. Lang
|
7 |
2008 |
7
🦁
|
